News
News
- CRISPR Therapeutics to Participate in the 20th Annual Needham Virtual Healthcare Conference
04/06/2021 / 14:00 - GlobeNewswire - Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer
04/05/2021 / 22:05 - GlobeNewswire - Young Women In Bio (YWIB) Launches Fourth Annual Spring Into STEM Festival – Virtual Keynote Event Features Women Biotech Leaders in Gene Therapy
04/01/2021 / 16:00 - GlobeNewswire - GENMARK ALERT: Bragar Eagel & Squire, P.C. Investigates Recently Announced Tender Offer for GNMK and Encourages Investors to Contact the Firm
04/01/2021 / 01:50 - GlobeNewswire - Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
03/31/2021 / 10:00 - GlobeNewswire - 4D Molecular Therapeutics Reports Financial Results for the Year Ended December 31, 2020 and Provides Operational Highlights
03/25/2021 / 21:02 - GlobeNewswire - Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
03/24/2021 / 14:29 - GlobeNewswire - Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
03/24/2021 / 12:00 - GlobeNewswire - Basilea reports positive interim results from phase 2 study FIDES-01 for derazantinib in FGFR2 gene mutation- or amplification-positive patients with bile duct cancer (iCCA)
03/24/2021 / 07:15 - GlobeNewswire - Roche: Antibody cocktail 70% effective in preventing COVID deaths
03/23/2021 / 08:16 - TeleTrader
Real-time